(Q38160956)
Statements
1 reference
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial (English)
1 reference
Thomas E Hutson
Vladimir Lesovoy
Salman Al-Shukri
Oleg N Lipatov
Angel H Bair
Brad Rosbrook
Connie Chen
Sinil Kim
Nicholas J Vogelzang
25 October 2013
1 reference